Runx3 at the interface of immunity, inflammation and cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1855, Issue 2, 2015, Pages 131-143

  Lotem, Joseph ^a   Levanon, Ditsa ^a   Negreanu, Varda ^a   Bauer, Omri ^a   Hantisteanu, Shay ^a   Dicken, Joseph ^a   Groner, Yoram ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cancer; DNA methylation; Immunity; Inflammation; RUNX3; Tumor suppressor gene

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

CANCER MODEL; CARCINOGENESIS; CELL GROWTH; CELL VIABILITY; CLINICAL DATA REPOSITORY; EPITHELIUM; EPITHELIUM TUMOR; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENETIC ASSOCIATION; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNITY; INFLAMMATION; NEOPLASM; NONHUMAN; QUANTITATIVE STUDY; REVIEW; STOMACH; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 84963955565     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2015.01.004     Document Type: Review

References (150)

1. Levanon D., Groner Y. Structure and regulated expression of mammalian RUNX genes. Oncogene 2004, 23:4211-4219.
2. Levanon D., Negreanu V., Bernstein Y., Bar-Am I., Avivi L., Groner Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994, 23:425-432.
3. Avraham K.B., Levanon D., Negreanu V., Bernstein Y., Groner Y., Copeland N.G., Jenkins N.A. Mapping of the mouse homolog of the human runt domain gene, AML2, to the distal region of mouse chromosome 4. Genomics 1995, 25:603-605.
4. Levanon D., Bettoun D., Harris-Cerruti C., Woolf E., Negreanu V., Eilam R., Bernstein Y., Goldenberg D., Xiao C., Fliegauf M., Kremer E., Otto F., Brenner O., Lev-Tov A., Groner Y. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 2002, 21:3454-3463.
5. Yoshida C.A., Yamamoto H., Fujita T., Furuichi T., Ito K., Inoue K., Yamana K., Zanma A., Takada K., Ito Y., Komori T. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 2004, 18:952-963.
6. Raveh E., Cohen S., Levanon D., Groner Y., Gat U. Runx3 is involved in hair shape determination. Dev. Dyn. 2005, 233:1478-1487.
7. Cruz-Guilloty F., Pipkin M.E., Djuretic I.M., Levanon D., Lotem J., Lichtenheld M.G., Groner Y., Rao A. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 2009, 206:51-59.
8. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002, 111:621-633.
9. Woolf E., Xiao C., Fainaru O., Lotem J., Rosen D., Negreanu V., Bernstein Y., Goldenberg D., Brenner O., Berke G., Levanon D., Groner Y. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7731-7736.
10. Djuretic I.M., Levanon D., Negreanu V., Groner Y., Rao A., Ansel K.M. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 2007, 8:145-153.
11. Levanon D., Negreanu V., Lotem J., Rae-Bone K., Brenner O., Leshkowitz D., Groner Y. Runx3 regulates interleukin-15 dependent natural killer cell activation. Mol. Cell. Biol. 2014, 34:1158-1169.
12. Brenner O., Levanon D., Negreanu V., Golubkov O., Fainaru O., Woolf E., Groner Y. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:16016-16021.
13. Fainaru O., Woolf E., Lotem J., Yarmus M., Brenner O., Goldenberg D., Negreanu V., Bernstein Y., Levanon D., Jung S., Groner Y. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 2004, 23:969-979.
14. Woolf E., Brenner O., Goldenberg D., Levanon D., Groner Y. Runx3 regulates dendritic epidermal T cell development. Dev. Biol. 2007, 303:703-714.
15. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.C., Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
16. Subramaniam M.M., Chan J.Y., Yeoh K.G., Quek T., Ito K., Salto-Tellez M. Molecular pathology of RUNX3 in human carcinogenesis. Biochim. Biophys. Acta 2009, 1796:315-331.
17. Levanon D., Bernstein Y., Negreanu V., Bone K.R., Pozner A., Eilam R., Lotem J., Brenner O., Groner Y. Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function. EMBO Mol. Med. 2011, 3:593-604.
18. Bauer O., Hantisteanu S., Lotem J., Groner Y. Carcinogen-induced skin tumor development requires leukocytic expression of the transcription factor Runx3. Cancer Prev. Res. 2014, 7:913-926.
19. Carvalho R., Milne A.N., Polak M., Corver W.E., Offerhaus G.J., Weterman M.A. Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas. Oncogene 2005, 24:8252-8258.
20. Friedrich M.J., Rad R., Langer R., Voland P., Hoefler H., Schmid R.M., Prinz C., Gerhard M. Lack of RUNX3 regulation in human gastric cancer. J. Pathol. 2006, 210:141-146.
21. Kim T.H., Li F., Ferreiro-Neira I., Ho L.L., Luyten A., Nalapareddy K., Long H., Verzi M., Shivdasani R.A. Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity. Nature 2014, 506:511-515.
22. Kurklu B., Whitehead R.H., Ong E.K., Minamoto T., Fox J.G., Mann J.R., Judd L.M., Giraud A.S., Menheniott T.R. Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer. Oncogene 2015, (in press). 10.1038/onc.2014.233.
23. Levanon D., Brenner O., Negreanu V., Bettoun D., Woolf E., Eilam R., Lotem J., Gat U., Otto F., Speck N., Groner Y. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech. Dev. 2001, 109:413-417.
24. McDonald L., Ferrari N., Terry A., Bell M., Mohammed Z.M., Orange C., Jenkins A., Muller W.J., Gusterson B.A., Neil J.C., Edwards J., Morris J.S., Cameron E.R., Blyth K. RUNX2 in subtype specific breast cancer and mammary gland differentiation. Dis. Model Mech. 2014, 7:525-534.
25. Munoz J., Stange D.E., Schepers A.G., van de Wetering M., Koo B.K., Itzkovitz S., Volckmann R., Kung K.S., Koster J., Radulescu S., Myant K., Versteeg R., Sansom O.J., van Es J.H., Barker N., van Oudenaarden A., Mohammed S., Heck A.J., Clevers H. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J. 2012, 31:3079-3091.
26. Stange D.E., Koo B.K., Huch M., Sibbel G., Basak O., Lyubimova A., Kujala P., Bartfeld S., Koster J., Geahlen J.H., Peters P.J., van Es J.H., van de Wetering M., Mills J.C., Clevers H. Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell 2013, 155:357-368.
27. Treutlein B., Brownfield D.G., Wu A.R., Neff N.F., Mantalas G.L., Espinoza F.H., Desai T.J., Krasnow M.A., Quake S.R. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature 2014, 509:371-375.
28. Levanon D., Groner Y. Runx3-deficient mouse strains circa 2008: resemblance and dissimilarity. Blood Cells Mol. Dis. 2009, 43:1-5.
29. Lotem J., Levanon D., Negreanu V., Groner Y. The false paradigm of Runx3 function as tumor suppressor in gastric cancer. J. Cancer Ther. 2013, 4:16-25.
30. van Bragt M.P., Hu X., Xie Y., Li Z. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. eLife 2014, 3:03881.
31. Kim W.J., Kim E.J., Jeong P., Quan C., Kim J., Li Q.L., Yang J.O., Ito Y., Bae S.C. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res. 2005, 65:9347-9354.
32. Zang Z.J., Cutcutache I., Poon S.L., Zhang S.L., McPherson J.R., Tao J., Rajasegaran V., Heng H.L., Deng N., Gan A., Lim K.H., Ong C.K., Huang D., Chin S.Y., Tan I.B., Ng C.C., Yu W., Wu Y., Lee M., Wu J., Poh D., Wan W.K., Rha S.Y., So J., Salto-Tellez M., Yeoh K.G., Wong W.K., Zhu Y.J., Futreal P.A., Pang B., Ruan Y., Hillmer A.M., Bertrand D., Nagarajan N., Rozen S., Teh B.T., Tan P. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet. 2012, 44:570-574.
33. Wang K., Yuen S.T., Xu J., Lee S.P., Yan H.H., Shi S.T., Siu H.C., Deng S., Chu K.M., Law S., Chan K.H., Chan A.S., Tsui W.Y., Ho S.L., Chan A.K., Man J.L., Foglizzo V., Ng M.K., Chan A.S., Ching Y.P., Cheng G.H., Xie T., Fernandez J., Li V.S., Clevers H., Rejto P.A., Mao M., Leung S.Y. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 2014, 46:573-582.
34. The Cancer Genome Atlas Research Network Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014, 513:201-209.
35. Dulak A.M., Stojanov P., Peng S., Lawrence M.S., Fox C., Stewart C., Bandla S., Imamura Y., Schumacher S.E., Shefler E., McKenna A., Carter S.L., Cibulskis K., Sivachenko A., Saksena G., Voet D., Ramos A.H., Auclair D., Thompson K., Sougnez C., Onofrio R.C., Guiducci C., Beroukhim R., Zhou Z., Lin L., Lin J., Reddy R., Chang A., Landrenau R., Pennathur A., Ogino S., Luketich J.D., Golub T.R., Gabriel S.B., Lander E.S., Beer D.G., Godfrey T.E., Getz G., Bass A.J. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 2013, 45:478-486.
36. Jones S., Wang T.L., Shih Ie M., Mao T.L., Nakayama K., Roden R., Glas R., Slamon D., Diaz L.A., Vogelstein B., Kinzler K.W., Velculescu V.E., Papadopoulos N. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010, 330:228-231.
37. Kandoth C., McLellan M.D., Vandin F., Ye K., Niu B., Lu C., Xie M., Zhang Q., McMichael J.F., Wyczalkowski M.A., Leiserson M.D., Miller C.A., Welch J.S., Walter M.J., Wendl M.C., Ley T.J., Wilson R.K., Raphael B.J., Ding L. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502:333-339.
38. Liang H., Cheung L.W., Li J., Ju Z., Yu S., Stemke-Hale K., Dogruluk T., Lu Y., Liu X., Gu C., Guo W., Scherer S.E., Carter H., Westin S.N., Dyer M.D., Verhaak R.G., Zhang F., Karchin R., Liu C.G., Lu K.H., Broaddus R.R., Scott K.L., Hennessy B.T., Mills G.B. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res. 2012, 22:2120-2129.
39. Stephens P.J., Tarpey P.S., Davies H., Van Loo P., Greenman C., Wedge D.C., Nik-Zainal S., Martin S., Varela I., Bignell G.R., Yates L.R., Papaemmanuil E., Beare D., Butler A., Cheverton A., Gamble J., Hinton J., Jia M., Jayakumar A., Jones D., Latimer C., Lau K.W., McLaren S., McBride D.J., Menzies A., Mudie L., Raine K., Rad R., Chapman M.S., Teague J., Easton D., Langerod A., Lee M.T., Shen C.Y., Tee B.T., Huimin B.W., Broeks A., Vargas A.C., Turashvili G., Martens J., Fatima A., Miron P., Chin S.F., Thomas G., Boyault S., Mariani O., Lakhani S.R., van de Vijver M., van't Veer L., Foekens J., Desmedt C., Sotiriou C., Tutt A., Caldas C., Reis-Filho J.S., Aparicio S.A., Salomon A.V., Borresen-Dale A.L., Richardson A.L., Campbell P.J., Futreal P.A., Stratton M.R. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404.
40. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer genome landscapes. Science 2013, 339:1546-1558.
41. Wiegand K.C., Shah S.P., Al-Agha O.M., Zhao Y., Tse K., Zeng T., Senz J., McConechy M.K., Anglesio M.S., Kalloger S.E., Yang W., Heravi-Moussavi A., Giuliany R., Chow C., Fee J., Zayed A., Prentice L., Melnyk N., Turashvili G., Delaney A.D., Madore J., Yip S., McPherson A.W., Ha G., Bell L., Fereday S., Tam A., Galletta L., Tonin P.N., Provencher D., Miller D., Jones S.J., Moore R.A., Morin G.B., Oloumi A., Boyd N., Aparicio S.A., Shih Ie M., Mes-Masson A.M., Bowtell D.D., Hirst M., Gilks B., Marra M.A., Huntsman D.G. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 2010, 363:1532-1543.
42. Wu J.N., Roberts C.W. ARID1A mutations in cancer: another epigenetic tumor suppressor?. Cancer Discov. 2013, 3:35-43.
43. Lawrence M.S., Stojanov P., Mermel C.H., Robinson J.T., Garraway L.A., Golub T.R., Meyerson M., Gabriel S.B., Lander E.S., Getz G. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014, 505:495-501.
44. Shain A.H., Giacomini C.P., Matsukuma K., Karikari C.A., Bashyam M.D., Hidalgo M., Maitra A., Pollack J.R. Convergent structural alterations define SWItch/Sucrose nonfermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E252-E259.
45. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., Mc Henry K.T., Pinchback R.M., Ligon A.H., Cho Y.J., Haery L., Greulich H., Reich M., Winckler W., Lawrence M.S., Weir B.A., Tanaka K.E., Chiang D.Y., Bass A.J., Loo A., Hoffman C., Prensner J., Liefeld T., Gao Q., Yecies D., Signoretti S., Maher E., Kaye F.J., Sasaki H., Tepper J.E., Fletcher J.A., Tabernero J., Baselga J., Tsao M.S., Demichelis F., Rubin M.A., Janne P.A., Daly M.J., Nucera C., Levine R.L., Ebert B.L., Gabriel S., Rustgi A.K., Antonescu C.R., Ladanyi M., Letai A., Garraway L.A., Loda M., Beer D.G., True L.D., Okamoto A., Pomeroy S.L., Singer S., Golub T.R., Lander E.S., Getz G., Sellers W.R., Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
46. Zack T.I., Schumacher S.E., Carter S.L., Cherniack A.D., Saksena G., Tabak B., Lawrence M.S., Zhang C.Z., Wala J., Mermel C.H., Sougnez C., Gabriel S.B., Hernandez B., Shen H., Laird P.W., Getz G., Meyerson M., Beroukhim R. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 2013, 45:1134-1140.
47. Bagchi A., Mills A.A. The quest for the 1p36 tumor suppressor. Cancer Res. 2008, 68:2551-2556.
48. Chun N., Ford J.M. Genetic testing by cancer site: stomach. Cancer J. 2012, 18:355-363.
49. Melchor L., Benitez J. The complex genetic landscape of familial breast cancer. Hum. Genet. 2013, 132:845-863.
50. Burt R. Inheritance of colorectal cancer. Drug Discov. Today Dis. Mech. 2007, 4:293-300.
51. Keller G., Vogelsang H., Becker I., Plaschke S., Ott K., Suriano G., Mateus A.R., Seruca R., Biedermann K., Huntsman D., Doring C., Holinski-Feder E., Neutzling A., Siewert J.R., Hofler H. Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J. Med. Genet. 2004, 41:e89.
52. Wu D., Tian Y., Gong W., Zhu H., Zhang Z., Wang M., Wang S., Tan M., Wu H. Genetic variants in the Runt-related transcription factor 3 gene contribute to gastric cancer risk in a Chinese population. Cancer Sci. 2009, 100:1688-1694.
53. Hishida A., Matsuo K., Goto Y., Mitsuda Y., Naito M., Wakai K., Tajima K., Hamajima N. Significant association of RUNX3 T/A polymorphism at intron 3 (rs760805) with the risk of gastric atrophy in Helicobacter pylori seropositive Japanese. J. Gastroenterol. 2009, 44:1165-1171.
54. Yamazaki K., Umeno J., Takahashi A., Hirano A., Johnson T.A., Kumasaka N., Morizono T., Hosono N., Kawaguchi T., Takazoe M., Yamada T., Suzuki Y., Tanaka H., Motoya S., Hosokawa M., Arimura Y., Shinomura Y., Matsui T., Matsumoto T., Iida M., Tsunoda T., Nakamura Y., Kamatani N., Kubo M. A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population. Gastroenterology 2013, 144:781-788.
55. Abnet C.C., Freedman N.D., Hu N., Wang Z., Yu K., Shu X.O., Yuan J.M., Zheng W., Dawsey S.M., Dong L.M., Lee M.P., Ding T., Qiao Y.L., Gao Y.T., Koh W.P., Xiang Y.B., Tang Z.Z., Fan J.H., Wang C., Wheeler W., Gail M.H., Yeager M., Yuenger J., Hutchinson A., Jacobs K.B., Giffen C.A., Burdett L., Fraumeni J.F., Tucker M.A., Chow W.H., Goldstein A.M., Chanock S.J., Taylor P.R. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 2010, 42:764-767.
56. Sakamoto H., Yoshimura K., Saeki N., Katai H., Shimoda T., Matsuno Y., Saito D., Sugimura H., Tanioka F., Kato S., Matsukura N., Matsuda N., Nakamura T., Hyodo I., Nishina T., Yasui W., Hirose H., Hayashi M., Toshiro E., Ohnami S., Sekine A., Sato Y., Totsuka H., Ando M., Takemura R., Takahashi Y., Ohdaira M., Aoki K., Honmyo I., Chiku S., Aoyagi K., Sasaki H., Ohnami S., Yanagihara K., Yoon K.A., Kook M.C., Lee Y.S., Park S.R., Kim C.G., Choi I.J., Yoshida T., Nakamura Y., Hirohashi S. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat. Genet. 2008, 40:730-740.
57. Shi Y., Hu Z., Wu C., Dai J., Li H., Dong J., Wang M., Miao X., Zhou Y., Lu F., Zhang H., Hu L., Jiang Y., Li Z., Chu M., Ma H., Chen J., Jin G., Tan W., Wu T., Zhang Z., Lin D., Shen H. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat. Genet. 2011, 43:1215-1218.
58. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., Wareham N., Ahmed S., Healey C.S., Bowman R., Meyer K.B., Haiman C.A., Kolonel L.K., Henderson B.E., Le Marchand L., Brennan P., Sangrajrang S., Gaborieau V., Odefrey F., Shen C.Y., Wu P.E., Wang H.C., Eccles D., Evans D.G., Peto J., Fletcher O., Johnson N., Seal S., Stratton M.R., Rahman N., Chenevix-Trench G., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Garcia-Closas M., Brinton L., Chanock S., Lissowska J., Peplonska B., Nevanlinna H., Fagerholm R., Eerola H., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Hunter D.J., Hankinson S.E., Cox D.G., Hall P., Wedren S., Liu J., Low Y.L., Bogdanova N., Schurmann P., Dork T., Tollenaar R.A., Jacobi C.E., Devilee P., Klijn J.G., Sigurdson A.J., Doody M.M., Alexander B.H., Zhang J., Cox A., Brock I.W., MacPherson G., Reed M.W., Couch F.J., Goode E.L., Olson J.E., Meijers-Heijboer H., van den Ouweland A., Uitterlinden A., Rivadeneira F., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Hopper J.L., McCredie M., Southey M., Giles G.G., Schroen C., Justenhoven C., Brauch H., Hamann U., Ko Y.D., Spurdle A.B., Beesley J., Chen X., Mannermaa A., Kosma V.M., Kataja V., Hartikainen J., Day N.E., Cox D.R., Ponder B.A. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
59. Fanale D., Amodeo V., Corsini L.R., Rizzo S., Bazan V., Russo A. Breast cancer genome-wide association studies: there is strength in numbers. Oncogene 2012, 31:2121-2128.
60. Ghoussaini M., Fletcher O., Michailidou K., Turnbull C., Schmidt M.K., Dicks E., Dennis J., Wang Q., Humphreys M.K., Luccarini C., Baynes C., Conroy D., Maranian M., Ahmed S., Driver K., Johnson N., Orr N., dos Santos Silva I., Waisfisz Q., Meijers-Heijboer H., Uitterlinden A.G., Rivadeneira F., Hall P., Czene K., Irwanto A., Liu J., Nevanlinna H., Aittomaki K., Blomqvist C., Meindl A., Schmutzler R.K., Muller-Myhsok B., Lichtner P., Chang-Claude J., Hein R., Nickels S., Flesch-Janys D., Tsimiklis H., Makalic E., Schmidt D., Bui M., Hopper J.L., Apicella C., Park D.J., Southey M., Hunter D.J., Chanock S.J., Broeks A., Verhoef S., Hogervorst F.B., Fasching P.A., Lux M.P., Beckmann M.W., Ekici A.B., Sawyer E., Tomlinson I., Kerin M., Marme F., Schneeweiss A., Sohn C., Burwinkel B., Guenel P., Truong T., Cordina-Duverger E., Menegaux F., Bojesen S.E., Nordestgaard B.G., Nielsen S.F., Flyger H., Milne R.L., Alonso M.R., Gonzalez-Neira A., Benitez J., Anton-Culver H., Ziogas A., Bernstein L., Dur C.C., Brenner H., Muller H., Arndt V., Stegmaier C., Justenhoven C., Brauch H., Bruning T., Wang-Gohrke S., Eilber U., Dork T., Schurmann P., Bremer M., Hillemanns P., Bogdanova N.V., Antonenkova N.N., Rogov Y.I., Karstens J.H., Bermisheva M., Prokofieva D., Khusnutdinova E., Lindblom A., Margolin S., Mannermaa A., Kataja V., Kosma V.M., Hartikainen J.M., Lambrechts D., Yesilyurt B.T., Floris G., Leunen K., Manoukian S., Bonanni B., Fortuzzi S., Peterlongo P., Couch F.J., Wang X., Stevens K., Lee A., Giles G.G., Baglietto L., Severi G., McLean C., Alnaes G.G., Kristensen V., Borrensen-Dale A.L., John E.M., Miron A., Winqvist R., Pylkas K., Jukkola-Vuorinen A., Kauppila S., Andrulis I.L., Glendon G., Mulligan A.M., Devilee P., van Asperen C.J., Tollenaar R.A., Seynaeve C., Figueroa J.D., Garcia-Closas M., Brinton L., Lissowska J., Hooning M.J., Hollestelle A., Oldenburg R.A., van den Ouweland A.M., Cox A., Reed M.W., Shah M., Jakubowska A., Lubinski J., Jaworska K., Durda K., Jones M., Schoemaker M., Ashworth A., Swerdlow A., Beesley J., Chen X., Muir K.R., Lophatananon A., Rattanamongkongul S., Chaiwerawattana A., Kang D., Yoo K.Y., Noh D.Y., Shen C.Y., Yu J.C., Wu P.E., Hsiung C.N., Perkins A., Swann R., Velentzis L., Eccles D.M., Tapper W.J., Gerty S.M., Graham N.J., Ponder B.A., Chenevix-Trench G., Pharoah P.D., Lathrop M., Dunning A.M., Rahman N., Peto J., Easton D.F. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet. 2012, 44:312-318.
61. Sapkota Y., Yasui Y., Lai R., Sridharan M., Robson P.J., Cass C.E., Mackey J.R., Damaraju S. Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm. PLoS One 2013, 8:e62550.
62. Turnbull C., Ahmed S., Morrison J., Pernet D., Renwick A., Maranian M., Seal S., Ghoussaini M., Hines S., Healey C.S., Hughes D., Warren-Perry M., Tapper W., Eccles D., Evans D.G., Hooning M., Schutte M., van den Ouweland A., Houlston R., Ross G., Langford C., Pharoah P.D., Stratton M.R., Dunning A.M., Rahman N., Easton D.F. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 2010, 42:504-507.
63. Tenesa A., Dunlop M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 2009, 10:353-358.
64. Peters U., Hutter C.M., Hsu L., Schumacher F.R., Conti D.V., Carlson C.S., Edlund C.K., Haile R.W., Gallinger S., Zanke B.W., Lemire M., Rangrej J., Vijayaraghavan R., Chan A.T., Hazra A., Hunter D.J., Ma J., Fuchs C.S., Giovannucci E.L., Kraft P., Liu Y., Chen L., Jiao S., Makar K.W., Taverna D., Gruber S.B., Rennert G., Moreno V., Ulrich C.M., Woods M.O., Green R.C., Parfrey P.S., Prentice R.L., Kooperberg C., Jackson R.D., Lacroix A.Z., Caan B.J., Hayes R.B., Berndt S.I., Chanock S.J., Schoen R.E., Chang-Claude J., Hoffmeister M., Brenner H., Frank B., Bezieau S., Kury S., Slattery M.L., Hopper J.L., Jenkins M.A., Le Marchand L., Lindor N.M., Newcomb P.A., Seminara D., Hudson T.J., Duggan D.J., Potter J.D., Casey G. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum. Genet. 2012, 131:217-234.
65. Zhang B., Jia W.H., Matsuda K., Kweon S.S., Matsuo K., Xiang Y.B., Shin A., Jee S.H., Kim D.H., Cai Q., Long J., Shi J., Wen W., Yang G., Zhang Y., Li C., Li B., Guo Y., Ren Z., Ji B.T., Pan Z.Z., Takahashi A., Shin M.H., Matsuda F., Gao Y.T., Oh J.H., Kim S., Ahn Y.O., Chan A.T., Chang-Claude J., Slattery M.L., Gruber S.B., Schumacher F.R., Stenzel S.L., Casey G., Kim H.R., Jeong J.Y., Park J.W., Li H.L., Hosono S., Cho S.H., Kubo M., Shu X.O., Zeng Y.X., Zheng W. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat. Genet. 2014, 46:533-542.
66. Shi Y., Li L., Hu Z., Li S., Wang S., Liu J., Wu C., He L., Zhou J., Li Z., Hu T., Chen Y., Jia Y., Wang S., Wu L., Cheng X., Yang Z., Yang R., Li X., Huang K., Zhang Q., Zhou H., Tang F., Chen Z., Shen J., Jiang J., Ding H., Xing H., Zhang S., Qu P., Song X., Lin Z., Deng D., Xi L., Lv W., Han X., Tao G., Yan L., Han Z., Li Z., Miao X., Pan S., Shen Y., Wang H., Liu D., Gong E., Li Z., Zhou L., Luan X., Wang C., Song Q., Wu S., Xu H., Shen J., Qiang F., Ma G., Liu L., Chen X., Liu J., Wu J., Shen Y., Wen Y., Chu M., Yu J., Hu X., Fan Y., He H., Jiang Y., Lei Z., Liu C., Chen J., Zhang Y., Yi C., Chen S., Li W., Wang D., Wang Z., Di W., Shen K., Lin D., Shen H., Feng Y., Xie X., Ma D. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat. Genet. 2013, 45:918-922.
67. Lan Q., Hsiung C.A., Matsuo K., Hong Y.C., Seow A., Wang Z.M., Hosgood H.D., Chen K.X., Wang J.C., Chatterjee N., Hu W., Wong M.P., Zheng W., Caporaso N., Park J.Y., Chen C.J., Kim Y.H., Kim Y.T., Landi M.T., Shen H.B., Lawrence C., Burdett L., Yeager M., Yuenger J., Jacobs K.B., Chang I.S., Mitsudomi T., Kim H.N., Chang G.C., Bassig B.A., Tucker M., Wei F.S., Yin Z.H., Wu C., An S.J., Qian B.Y., Lee V.H.F., Lu D.R., Liu J.J., Jeon H.S., Hsiao C.F., Sung J.S., Kim J.H., Gao Y.T., Tsai Y.H., Jung Y.J., Guo H., Hu Z.B., Hutchinson A., Wang W.C., Klein R., Chung C.C., Oh I.J., Chen K.Y., Berndt S.I., He X.Z., Wu W., Chang J., Zhang X.C., Huang M.S., Zheng H., Wang J.W., Zhao X.Y., Li Y.Q., Choi J.E., Su W.C., Park K.H., Sung S.W., Shu X.O., Chen Y.M., Liu L., Kang C.H., Hu L.M., Chen C.H., Pao W., Kim Y.C., Yang T.Y., Xu J., Guan P., Tan W., Su J., Wang C.L., Li H.X., Sihoe A.D.L., Zhao Z.H., Chen Y., Choi Y.Y., Hung J.Y., Kim J.S., Yoon H.I., Cai Q.Y., Lin C.C., Park I.K., Xu P., Dong J., Kim C., He Q.C., Perng R.P., Kohno T., Kweon S.S., Chen C.Y., Vermeulen R., Wu J.J., Lim W.Y., Chen K.C., Chow W.H., Ji B.T., Chan J.K.C., Chu M.J., Li Y.J., Yokota J., Li J.H., Chen H.Y., Xiang Y.B., Yu C.J., Kunitoh H., Wu G.P., Jin L., Lo Y.L., Shiraishi K., Chen Y.H., Lin H.C., Wu T.C., Wu Y.L., Yang P.C., Zhou B.S., Shin M.H., Fraumeni J.F., Lin D.X., Chanock S.J., Rothman N. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat. Genet. 2012, 44:1330-1335.
68. Landi M.T., Chatterjee N., Yu K., Goldin L.R., Goldstein A.M., Rotunno M., Mirabello L., Jacobs K., Wheeler W., Yeager M., Bergen A.W., Li Q.Z., Consonni D., Pesatori A.C., Wacholder S., Thun M., Diver R., Oken M., Virtamo J., Albanes D., Wang Z.M., Burdette L., Doheny K.F., Pugh E.W., Laurie C., Brennan P., Hung R., Gaborieau V., McKay J.D., Lathrop M., McLaughlin J., Wang Y., Tsao M.S., Spitz M.R., Wang Y.F., Krokan H., Vatten L., Skorpen F., Arnesen E., Benhamou S., Bouchard C., Metsapalu A., Vooder T., Nelis M., Valk K., Field J.K., Chen C., Goodman G., Sulem P., Thorleifsson G., Rafnar T., Eisen T., Sauter W., Rosenberger A., Bickeboller H., Risch A., Chang-Claude J., Wichmann H.E., Stefansson K., Houlston R., Amos C.I., Fraumeni J.F., Savage S.A., Bertazzi P.A., Tucker M.A., Chanock S., Caporaso N.E. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet. 2009, 85:679-691.
69. Wang Y.F., Broderick P., Webb E., Wu X.F., Vijayakrishnan J., Matakidou A., Qureshi M., Dong Q., Gu X.J., Chen W.V., Spitz M.R., Eisen T., Amos C.I., Houlston R.S. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet. 2008, 40:1407-1409.
70. Pharoah P.D., Tsai Y.Y., Ramus S.J., Phelan C.M., Goode E.L., Lawrenson K., Buckley M., Fridley B.L., Tyrer J.P., Shen H., Weber R., Karevan R., Larson M.C., Song H., Tessier D.C., Bacot F., Vincent D., Cunningham J.M., Dennis J., Dicks E., Aben K.K., Anton-Culver H., Antonenkova N., Armasu S.M., Baglietto L., Bandera E.V., Beckmann M.W., Birrer M.J., Bloom G., Bogdanova N., Brenton J.D., Brinton L.A., Brooks-Wilson A., Brown R., Butzow R., Campbell I., Carney M.E., Carvalho R.S., Chang-Claude J., Chen Y.A., Chen Z., Chow W.H., Cicek M.S., Coetzee G., Cook L.S., Cramer D.W., Cybulski C., Dansonka-Mieszkowska A., Despierre E., Doherty J.A., Dork T., du Bois A., Durst M., Eccles D., Edwards R., Ekici A.B., Fasching P.A., Fenstermacher D., Flanagan J., Gao Y.T., Garcia-Closas M., Gentry-Maharaj A., Giles G., Gjyshi A., Gore M., Gronwald J., Guo Q., Halle M.K., Harter P., Hein A., Heitz F., Hillemanns P., Hoatlin M., Hogdall E., Hogdall C.K., Hosono S., Jakubowska A., Jensen A., Kalli K.R., Karlan B.Y., Kelemen L.E., Kiemeney L.A., Kjaer S.K., Konecny G.E., Krakstad C., Kupryjanczyk J., Lambrechts D., Lambrechts S., Le N.D., Lee N., Lee J., Leminen A., Lim B.K., Lissowska J., Lubinski J., Lundvall L., Lurie G., Massuger L.F., Matsuo K., McGuire V., McLaughlin J.R., Menon U., Modugno F., Moysich K.B., Nakanishi T., Narod S.A., Ness R.B., Nevanlinna H., Nickels S., Noushmehr H., Odunsi K., Olson S., Orlow I., Paul J., Pejovic T., Pelttari L.M., Permuth-Wey J., Pike M.C., Poole E.M., Qu X., Risch H.A., Rodriguez-Rodriguez L., Rossing M.A., Rudolph A., Runnebaum I., Rzepecka I.K., Salvesen H.B., Schwaab I., Severi G., Shen H., Shridhar V., Shu X.O., Sieh W., Southey M.C., Spellman P., Tajima K., Teo S.H., Terry K.L., Thompson P.J., Timorek A., Tworoger S.S., van Altena A.M., van den Berg D., Vergote I., Vierkant R.A., Vitonis A.F., Wang-Gohrke S., Wentzensen N., Whittemore A.S., Wik E., Winterhoff B., Woo Y.L., Wu A.H., Yang H.P., Zheng W., Ziogas A., Zulkifli F., Goodman M.T., Hall P., Easton D.F., Pearce C.L., Berchuck A., Chenevix-Trench G., Iversen E., Monteiro A.N., Gayther S.A., Schildkraut J.M., Sellers T.A. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat. Genet. 2013, 45:362-370.
71. Al Olama A.A., Kote-Jarai Z., Schumacher F.R., Wiklund F., Berndt S.I., Benlloch S., Giles G.G., Severi G., Neal D.E., Hamdy F.C., Donovan J.L., Hunter D.J., Henderson B.E., Thun M.J., Gaziano M., Giovannucci E.L., Siddiq A., Travis R.C., Cox D.G., Canzian F., Riboli E., Key T.J., Andriole G., Albanes D., Hayes R.B., Schleutker J., Auvinen A., Tammela T.L.J., Weischer M., Stanford J.L., Ostrander E.A., Cybulski C., Lubinski J., Thibodeau S.N., Schaid D.J., Sorensen K.D., Batra J., Clements J.A., Chambers S., Aitken J., Gardiner R.A., Maier C., Vogel W., Dork T., Brenner H., Habuchi T., Ingles S., John E.M., Dickinson J.L., Cannon-Albright L., Teixeira M.R., Kaneva R., Zhang H.W., Lu Y.J., Park J.Y., Cooney K.A., Muir K.R., Leongamornlert D.A., Saunders E., Tymrakiewicz M., Mahmud N., Guy M., Govindasami K., O'Brien L.T., Wilkinson R.A., Hall A.L., Sawyer E.J., Dadaev T., Morrison J., Dearnaley D.P., Horwich A., Huddart R.A., Khoo V.S., Parker C.C., Van As N., Woodhouse C.J., Thompson A., Dudderidge T., Ogden C., Cooper C.S., Lophatonanon A., Southey M.C., Hopper J.L., English D., Virtamo J., Le Marchand L., Campa D., Kaaks R., Lindstrom S., Diver W.R., Gapstur S., Yeager M., Cox A., Stern M.C., Corral R., Aly M., Isaacs W., Adolfsson J., Xu J.F., Zheng S.L., Wahlfors T., Taari K., Kujala P., Klarskov P., Nordestgaard B.G., Roder M.A., Frikke-Schmidt R., Bojesen S.E., FitzGerald L.M., Kolb S., Kwon E.M., Karyadi D.M., Orntoft T.F., Borre M., Rinckleb A., Luedeke M., Herkommer K., Meyer A., Serth J., Marthick J.R., Patterson B., Wokolorczyk D., Spurdle A., Lose F., McDonnell S.K., Joshi A.D., Shahabi A., Pinto P., Santos J., Ray A., Sellers T.A., Lin H.Y., Stephenson R.A., Teerlink C., Muller H., Rothenbacher D., Tsuchiya N., Narita S., Cao G.W., Slavov C., Mitev V., Chanock S., Gronberg H., Haiman C.A., Kraft P., Easton D.F., Eeles R.A. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum. Mol. Genet. 2013, 22:408-415.
72. Eeles R.A., Olama A.A., Benlloch S., Saunders E.J., Leongamornlert D.A., Tymrakiewicz M., Ghoussaini M., Luccarini C., Dennis J., Jugurnauth-Little S., Dadaev T., Neal D.E., Hamdy F.C., Donovan J.L., Muir K., Giles G.G., Severi G., Wiklund F., Gronberg H., Haiman C.A., Schumacher F., Henderson B.E., Le Marchand L., Lindstrom S., Kraft P., Hunter D.J., Gapstur S., Chanock S.J., Berndt S.I., Albanes D., Andriole G., Schleutker J., Weischer M., Canzian F., Riboli E., Key T.J., Travis R.C., Campa D., Ingles S.A., John E.M., Hayes R.B., Pharoah P.D., Pashayan N., Khaw K.T., Stanford J.L., Ostrander E.A., Signorello L.B., Thibodeau S.N., Schaid D., Maier C., Vogel W., Kibel A.S., Cybulski C., Lubinski J., Cannon-Albright L., Brenner H., Park J.Y., Kaneva R., Batra J., Spurdle A.B., Clements J.A., Teixeira M.R., Dicks E., Lee A., Dunning A.M., Baynes C., Conroy D., Maranian M.J., Ahmed S., Govindasami K., Guy M., Wilkinson R.A., Sawyer E.J., Morgan A., Dearnaley D.P., Horwich A., Huddart R.A., Khoo V.S., Parker C.C., Van As N.J., Woodhouse C.J., Thompson A., Dudderidge T., Ogden C., Cooper C.S., Lophatananon A., Cox A., Southey M.C., Hopper J.L., English D.R., Aly M., Adolfsson J., Xu J., Zheng S.L., Yeager M., Kaaks R., Diver W.R., Gaudet M.M., Stern M.C., Corral R., Joshi A.D., Shahabi A., Wahlfors T., Tammela T.L., Auvinen A., Virtamo J., Klarskov P., Nordestgaard B.G., Roder M.A., Nielsen S.F., Bojesen S.E., Siddiq A., Fitzgerald L.M., Kolb S., Kwon E.M., Karyadi D.M., Blot W.J., Zheng W., Cai Q., McDonnell S.K., Rinckleb A.E., Drake B., Colditz G., Wokolorczyk D., Stephenson R.A., Teerlink C., Muller H., Rothenbacher D., Sellers T.A., Lin H.Y., Slavov C., Mitev V., Lose F., Srinivasan S., Maia S., Paulo P., Lange E., Cooney K.A., Antoniou A.C., Vincent D., Bacot F., Tessier D.C., Kote-Jarai Z., Easton D.F. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat. Genet. 2013, 45:385-391.
73. Deng N., Goh L.K., Wang H., Das K., Tao J., Tan I.B., Zhang S., Lee M., Wu J., Lim K.H., Lei Z., Goh G., Lim Q.Y., Tan A.L., Sin Poh D.Y., Riahi S., Bell S., Shi M.M., Linnartz R., Zhu F., Yeoh K.G., Toh H.C., Yong W.P., Cheong H.C., Rha S.Y., Boussioutas A., Grabsch H., Rozen S., Tan P. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 2012, 61:673-684.
74. Fan B., Dachrut S., Coral H., Yuen S.T., Chu K.M., Law S., Zhang L., Ji J., Leung S.Y., Chen X. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer. PLoS One 2012, 7:e29824.
75. Tsukamoto Y., Uchida T., Karnan S., Noguchi T., Nguyen L.T., Tanigawa M., Takeuchi I., Matsuura K., Hijiya N., Nakada C., Kishida T., Kawahara K., Ito H., Murakami K., Fujioka T., Seto M., Moriyama M. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J. Pathol. 2008, 216:471-482.
76. Zhao C., Bu X. Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol. Histopathol. 2012, 27:1271-1282.
77. Hu S.L., Huang D.B., Sun Y.B., Wu L., Xu W.P., Yin S., Chen J., Jiang X.D., Shen G. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. Med. Oncol. 2011, 28:447-454.
78. Tamura G., So K., Miyoshi H., Honda T., Nishizuka S., Motoyama T. Quantitative assessment of gene methylation in neoplastic and non-neoplastic gastric epithelia using methylation-specific DNA microarray. Pathol. Int. 2009, 59:895-899.
79. Dedeurwaerder S., Desmedt C., Calonne E., Singhal S.K., Haibe-Kains B., Defrance M., Michiels S., Volkmar M., Deplus R., Luciani J., Lallemand F., Larsimont D., Toussaint J., Haussy S., Rothe F., Rouas G., Metzger O., Majjaj S., Saini K., Putmans P., Hames G., van Baren N., Coulie P.G., Piccart M., Sotiriou C., Fuks F. DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO Mol. Med. 2011, 3:726-741.
80. Kibriya M.G., Raza M., Jasmine F., Roy S., Paul-Brutus R., Rahaman R., Dodsworth C., Rakibuz-Zaman M., Kamal M., Ahsan H. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med. Genomics 2011, 4:50.
81. Naumov V.A., Generozov E.V., Zaharjevskaya N.B., Matushkina D.S., Larin A.K., Chernyshov S.V., Alekseev M.V., Shelygin Y.A., Govorun V.M. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics 2013, 8:8.
82. Park J.H., Park J., Choi J.K., Lyu J., Bae M.G., Lee Y.G., Bae J.B., Park D.Y., Yang H.K., Kim T.Y., Kim Y.J. Identification of DNA methylation changes associated with human gastric cancer. BMC Med. Genomics 2011, 4:82.
83. Van der Auwera I., Yu W., Suo L., Van Neste L., van Dam P., Van Marck E.A., Pauwels P., Vermeulen P.B., Dirix L.Y., Van Laere S.J. Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One 2010, 5:e12616.
84. Zouridis H., Deng N., Ivanova T., Zhu Y., Wong B., Huang D., Wu Y.H., Wu Y., Tan I.B., Liem N., Gopalakrishnan V., Luo Q., Wu J., Lee M., Yong W.P., Goh L.K., Teh B.T., Rozen S., Tan P. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci. Transl. Med. 2012, 4:156ra140.
85. Sproul D., Nestor C., Culley J., Dickson J.H., Dixon J.M., Harrison D.J., Meehan R.R., Sims A.H., Ramsahoye B.H. Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4364-4369.
86. Gal-Yam E.N., Egger G., Iniguez L., Holster H., Einarsson S., Zhang X., Lin J.C., Liang G., Jones P.A., Tanay A. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12979-12984.
87. Keshet I., Schlesinger Y., Farkash S., Rand E., Hecht M., Segal E., Pikarski E., Young R.A., Niveleau A., Cedar H., Simon I. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 2006, 38:149-153.
88. Song H.J., Shim K.N., Joo Y.H., Kim S.E., Jung S.A., Yoo K. Methylation of the tumor suppressor gene RUNX3 in human gastric carcinoma. Gut Liver 2008, 2:119-125.
89. Landan G., Cohen N.M., Mukamel Z., Bar A., Molchadsky A., Brosh R., Horn-Saban S., Zalcenstein D.A., Goldfinger N., Zundelevich A., Gal-Yam E.N., Rotter V., Tanay A. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat. Genet. 2012, 44:1207-1214.
90. Beerman I., Bock C., Garrison B.S., Smith Z.D., Gu H., Meissner A., Rossi D.J. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 2013, 12:413-425.
91. Bagchi A., Papazoglu C., Wu Y., Capurso D., Brodt M., Francis D., Bredel M., Vogel H., Mills A.A. CHD5 is a tumor suppressor at human 1p36. Cell 2007, 128:459-475.
92. Birnbaum D.J., Adelaide J., Mamessier E., Finetti P., Lagarde A., Monges G., Viret F., Goncalves A., Turrini O., Delpero J.R., Iovanna J., Giovannini M., Birnbaum D., Chaffanet M. Genome profiling of pancreatic adenocarcinoma. Genes Chromosom. Cancer 2011, 50:456-465.
93. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
94. Katajisto P., Vaahtomeri K., Ekman N., Ventela E., Ristimaki A., Bardeesy N., Feil R., DePinho R.A., Makela T.P. LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nat. Genet. 2008, 40:455-459.
95. Lujambio A., Akkari L., Simon J., Grace D., Tschaharganeh D.F., Bolden J.E., Zhao Z., Thapar V., Joyce J.A., Krizhanovsky V., Lowe S.W. Non-cell-autonomous tumor suppression by p53. Cell 2013, 153:449-460.
96. Kim B.G., Li C., Qiao W., Mamura M., Kasprzak B., Anver M., Wolfraim L., Hong S., Mushinski E., Potter M., Kim S.J., Fu X.Y., Deng C., Letterio J.J. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006, 441:1015-1019.
97. Reis B.S., Hoytema van Konijnenburg D.P., Grivennikov S.I., Mucida D. Transcription factor T-bet regulates intraepithelial lymphocyte functional maturation. Immunity 2014, 41:244-256.
98. Reis B.S., Rogoz A., Costa-Pinto F.A., Taniuchi I., Mucida D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(+) T cell immunity. Nat. Immunol. 2013, 14:271-280.
99. Cheroutre H., Lambolez F., Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 2011, 11:445-456.
100. Levanon D., Hantisteanu S., Negreanu V., Brenner O., Groner Y. New insights into the mechanism of inflammatory bowel disease (IBD) etiology in Runx3-deficient mice. EMBO Worksop: RUNX Transcription Factors in Development & Disease 2009, 20.
101. Sugai M., Aoki K., Osato M., Nambu Y., Ito K., Taketo M.M., Shimizu A. Runx3 is required for full activation of regulatory T cells to prevent colitis-associated tumor formation. J. Immunol. 2011, 186:6515-6520.
102. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
103. Elinav E., Nowarski R., Thaiss C.A., Hu B., Jin C., Flavell R.A. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 2013, 13:759-771.
104. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J. Gastrointest. Oncol. 2012, 4:156-169.
105. Ito K., Lim A.C., Salto-Tellez M., Motoda L., Osato M., Chuang L.S., Lee C.W., Voon D.C., Koo J.K., Wang H., Fukamachi H., Ito Y. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 2008, 14:226-237.
106. Ito K., Chuang L.S., Ito T., Chang T.L., Fukamachi H., Salto-Tellez M., Ito Y. Loss of Runx3 is a key event in inducing precancerous state of the stomach. Gastroenterology 2011, 140. (1536-1546.e8).
107. Leung W.K., Wu K.C., Wong C.Y., Cheng A.S., Ching A.K., Chan A.W., Chong W.W., Go M.Y., Yu J., To K.F., Wang X., Chui Y.L., Fan D.M., Sung J.J. Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice. Carcinogenesis 2008, 29:1648-1654.
108. Oshima H., Ishikawa T., Yoshida G.J., Naoi K., Maeda Y., Naka K., Ju X., Yamada Y., Minamoto T., Mukaida N., Saya H., Oshima M. TNF-alpha/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells. Oncogene 2014, 33:3820-3829.
109. Li Q., Jia Z., Wang L., Kong X., Li Q., Guo K., Tan D., Le X., Wei D., Huang S., Mishra L., Xie K. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology 2012, 142:531-542.
110. Grim J.E., Knoblaugh S.E., Guthrie K.A., Hagar A., Swanger J., Hespelt J., Delrow J.J., Small T., Grady W.M., Nakayama K.I., Clurman B.E. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer. Mol. Cell. Biol. 2012, 32:2160-2167.
111. Berger A.H., Knudson A.G., Pandolfi P.P. A continuum model for tumour suppression. Nature 2011, 476:163-169.
112. Huang B., Qu Z., Ong C.W., Tsang Y.H.N., Xiao G., Shapiro D., Salto-Tellez M., Ito K., Ito Y., Chen L.F. RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor alpha. Oncogene 2012, 31:527-534.
113. Lee K.S., Lee Y.S., Lee J.M., Ito K., Cinghu S., Kim J.H., Jang J.W., Li Y.H., Goh Y.M., Chi X.Z., Wee H., Lee H.W., Hosoya A., Chung J.H., Jang J.J., Kundu J.K., Surh Y.J., Kim W.J., Ito Y., Jung H.S., Bae S.C. Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer. Oncogene 2010, 29:3349-3361.
114. Lee Y.S., Lee J.W., Jang J.W., Chi X.Z., Kim J.H., Li Y.H., Kim M.K., Kim D.M., Choi B.S., Kim E.G., Chung J.H., Lee O.J., Lee Y.M., Suh J.W., Chuang L.S., Ito Y., Bae S.C. Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma. Cancer Cell 2013, 24:603-616.
115. Ji H., Houghton A.M., Mariani T.J., Perera S., Kim C.B., Padera R., Tonon G., McNamara K., Marconcini L.A., Hezel A., El-Bardeesy N., Bronson R.T., Sugarbaker D., Maser R.S., Shapiro S.D., Wong K.K. K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006, 25:2105-2112.
116. Lin C., Song H., Huang C., Yao E., Gacayan R., Xu S.M., Chuang P.T. Alveolar type II cells possess the capability of initiating lung tumor development. PLoS One 2012, 7:e53817.
117. Wilderman M.J., Kim S., Gillespie C.T., Sun J., Kapoor V., Vachani A., Sterman D.H., Kaiser L.R., Albelda S.M. Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer. Mol. Ther. 2006, 13:910-917.
118. Lauber S. The role of gp130 cytokines IL-6 and OSM on tumor development in mouse models for lung adenocarcinoma. Open Access Dissertations and Theses 7325 2012, McMaster University, Hamilton, Ontario, (M.Sc).
119. Chan I.T., Kutok J.L., Williams I.R., Cohen S., Kelly L., Shigematsu H., Johnson L., Akashi K., Tuveson D.A., Jacks T., Gilliland D.G. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J. Clin. Invest. 2004, 113:528-538.
120. Cortez-Retamozo V., Etzrodt M., Newton A., Rauch P.J., Chudnovskiy A., Berger C., Ryan R.J., Iwamoto Y., Marinelli B., Gorbatov R., Forghani R., Novobrantseva T.I., Koteliansky V., Figueiredo J.L., Chen J.W., Anderson D.G., Nahrendorf M., Swirski F.K., Weissleder R., Pittet M.J. Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2491-2496.
121. Fritz J.M., Dwyer-Nield L.D., Malkinson A.M. Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation. Mol. Cancer 2011, 10:76.
122. Houghton A.M. Mechanistic links between COPD and lung cancer. Nat. Rev. Cancer 2013, 13:233-245.
123. Takahashi H., Ogata H., Nishigaki R., Broide D.H., Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010, 17:89-97.
124. Rundhaug J.E., Fischer S.M. Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) 2010, 2:436-482.
125. Winkler A.E., Brotman J.J., Pittman M.E., Judd N.P., Lewis J.S., Schreiber R.D., Uppaluri R. CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis. Cancer Res. 2011, 71:5707-5716.
126. Gebhardt C., Riehl A., Durchdewald M., Nemeth J., Furstenberger G., Muller-Decker K., Enk A., Arnold B., Bierhaus A., Nawroth P.P., Hess J., Angel P. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 2008, 205:275-285.
127. Salto-Tellez M., Peh B.K., Ito K., Tan S.H., Chong P.Y., Han H.C., Tada K., Ong W.Y., Soong R., Voon D.C., Ito Y. RUNX3 protein is overexpressed in human basal cell carcinomas. Oncogene 2006, 25:7646-7649.
128. Guo C., Yao F., Wu K., Yang L., Zhang X., Ding J. Chromatin immunoprecipitation and association study revealed a possible role of Runt-related transcription factor 3 in the ulcerative colitis of Chinese population. Clin. Immunol. 2010, 135:483-489.
129. Weersma R.K., Zhou L., Nolte I.M., van der Steege G., van Dullemen H.M., Oosterom E., Bok L., Peppelenbosch M.P., Faber K.N., Kleibeuker J.H., Dijkstra G. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Inflamm. Bowel Dis. 2008, 14:1615-1622.
130. Dubois P.C., Trynka G., Franke L., Hunt K.A., Romanos J., Curtotti A., Zhernakova A., Heap G.A., Adany R., Aromaa A., Bardella M.T., van den Berg L.H., Bockett N.A., de la Concha E.G., Dema B., Fehrmann R.S., Fernandez-Arquero M., Fiatal S., Grandone E., Green P.M., Groen H.J., Gwilliam R., Houwen R.H., Hunt S.E., Kaukinen K., Kelleher D., Korponay-Szabo I., Kurppa K., MacMathuna P., Maki M., Mazzilli M.C., McCann O.T., Mearin M.L., Mein C.A., Mirza M.M., Mistry V., Mora B., Morley K.I., Mulder C.J., Murray J.A., Nunez C., Oosterom E., Ophoff R.A., Polanco I., Peltonen L., Platteel M., Rybak A., Salomaa V., Schweizer J.J., Sperandeo M.P., Tack G.J., Turner G., Veldink J.H., Verbeek W.H., Weersma R.K., Wolters V.M., Urcelay E., Cukrowska B., Greco L., Neuhausen S.L., McManus R., Barisani D., Deloukas P., Barrett J.C., Saavalainen P., Wijmenga C., van Heel D.A. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 2010, 42:295-302.
131. Evans D.M., Spencer C.C., Pointon J.J., Su Z., Harvey D., Kochan G., Oppermann U., Dilthey A., Pirinen M., Stone M.A., Appleton L., Moutsianas L., Leslie S., Wordsworth T., Kenna T.J., Karaderi T., Thomas G.P., Ward M.M., Weisman M.H., Farrar C., Bradbury L.A., Danoy P., Inman R.D., Maksymowych W., Gladman D., Rahman P., Morgan A., Marzo-Ortega H., Bowness P., Gaffney K., Gaston J.S., Smith M., Bruges-Armas J., Couto A.R., Sorrentino R., Paladini F., Ferreira M.A., Xu H., Liu Y., Jiang L., Lopez-Larrea C., Diaz-Pena R., Lopez-Vazquez A., Zayats T., Band G., Bellenguez C., Blackburn H., Blackwell J.M., Bramon E., Bumpstead S.J., Casas J.P., Corvin A., Craddock N., Deloukas P., Dronov S., Duncanson A., Edkins S., Freeman C., Gillman M., Gray E., Gwilliam R., Hammond N., Hunt S.E., Jankowski J., Jayakumar A., Langford C., Liddle J., Markus H.S., Mathew C.G., McCann O.T., McCarthy M.I., Palmer C.N., Peltonen L., Plomin R., Potter S.C., Rautanen A., Ravindrarajah R., Ricketts M., Samani N., Sawcer S.J., Strange A., Trembath R.C., Viswanathan A.C., Waller M., Weston P., Whittaker P., Widaa S., Wood N.W., McVean G., Reveille J.D., Wordsworth B.P., Brown M.A., Donnelly P. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 2011, 43:761-767.
132. Tsoi L.C., Spain S.L., Knight J., Ellinghaus E., Stuart P.E., Capon F., Ding J., Li Y., Tejasvi T., Gudjonsson J.E., Kang H.M., Allen M.H., McManus R., Novelli G., Samuelsson L., Schalkwijk J., Stahle M., Burden A.D., Smith C.H., Cork M.J., Estivill X., Bowcock A.M., Krueger G.G., Weger W., Worthington J., Tazi-Ahnini R., Nestle F.O., Hayday A., Hoffmann P., Winkelmann J., Wijmenga C., Langford C., Edkins S., Andrews R., Blackburn H., Strange A., Band G., Pearson R.D., Vukcevic D., Spencer C.C., Deloukas P., Mrowietz U., Schreiber S., Weidinger S., Koks S., Kingo K., Esko T., Metspalu A., Lim H.W., Voorhees J.J., Weichenthal M., Wichmann H.E., Chandran V., Rosen C.F., Rahman P., Gladman D.D., Griffiths C.E., Reis A., Kere J., Duffin K.C., Helms C., Goldgar D., Li Y., Paschall J., Malloy M.J., Pullinger C.R., Kane J.P., Gardner J., Perlmutter A., Miner A., Feng B.J., Hiremagalore R., Ike R.W., Christophers E., Henseler T., Ruether A., Schrodi S.J., Prahalad S., Guthery S.L., Fischer J., Liao W., Kwok P., Menter A., Lathrop G.M., Wise C., Begovich A.B., Onoufriadis A., Weale M.E., Hofer A., Salmhofer W., Wolf P., Kainu K., Saarialho-Kere U., Suomela S., Badorf P., Huffmeier U., Kurrat W., Kuster W., Lascorz J., Mossner R., Schurmeier-Horst F., Stander M., Traupe H., Bergboer J.G., Heijer M.D., van de Kerkhof P.C., Zeeuwen P.L., Barnes L., Campbell L.E., Cusack C., Coleman C., Conroy J., Ennis S., Fitzgerald O., Gallagher P., Irvine A.D., Kirby B., Markham T., McLean W.H., McPartlin J., Rogers S.F., Ryan A.W., Zawirska A., Giardina E., Lepre T., Perricone C., Martin-Ezquerra G., Pujol R.M., Riveira-Munoz E., Inerot A., Naluai A.T., Mallbris L., Wolk K., Leman J., Barton A., Warren R.B., Young H.S., Ricano-Ponce I., Trynka G., Pellett F.J., Henschel A., Aurand M., Bebo B., Gieger C., Illig T., Moebus S., Jockel K.H., Erbel R., Donnelly P., Peltonen L., Blackwell J.M., Bramon E., Brown M.A., Casas J.P., Corvin A., Craddock N., Duncanson A., Jankowski J., Markus H.S., Mathew C.G., McCarthy M.I., Palmer C.N., Plomin R., Rautanen A., Sawcer S.J., Samani N., Viswanathan A.C., Wood N.W., Bellenguez C., Freeman C., Hellenthal G., Giannoulatou E., Pirinen M., Su Z., Hunt S.E., Gwilliam R., Bumpstead S.J., Dronov S., Gillman M., Gray E., Hammond N., Jayakumar A., McCann O.T., Liddle J., Perez M.L., Potter S.C., Ravindrarajah R., Ricketts M., Waller M., Weston P., Widaa S., Whittaker P., Nair R.P., Franke A., Barker J.N., Abecasis G.R., Elder J.T., Trembath R.C. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 2012, 44:1341-1348.
133. Esparza-Gordillo J., Schaarschmidt H., Liang L., Cookson W., Bauerfeind A., Lee-Kirsch M.A., Nemat K., Henderson J., Paternoster L., Harper J.I., Mangold E., Nothen M.M., Ruschendorf F., Kerscher T., Marenholz I., Matanovic A., Lau S., Keil T., Bauer C.P., Kurek M., Ciechanowicz A., Macek M., Franke A., Kabesch M., Hubner N., Abecasis G., Weidinger S., Moffatt M., Lee Y.A. A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis. J. Allergy Clin. Immunol. 2013, 132:371-377.
134. Apel M., Uebe S., Bowes J., Giardina E., Korendowych E., Juneblad K., Pasutto F., Ekici A.B., McManus R., Ho P., Bruce I.N., Ryan A.W., Behrens F., Bohm B., Traupe H., Lohmann J., Gieger C., Wichmann H.E., Padyukov L., FitzGerald O., Alenius G.M., McHugh N.J., Novelli G., Burkhardt H., Barton A., Reis A., Huffmeier U. Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis. Arthritis Rheum. 2013, 65:1224-1231.
135. Laprise C. The Saguenay-Lac-Saint-Jean asthma familial collection: the genetics of asthma in a young founder population. Genes Immun. 2014, 15:247-255.
136. Helms C., Cao L., Krueger J.G., Wijsman E.M., Chamian F., Gordon D., Heffernan M., Daw J.A., Robarge J., Ott J., Kwok P.Y., Menter A., Bowcock A.M. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 2003, 35:349-356.
137. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., Brookes A.J., Tentler D., Kristjansdottir H., Grondal G., Bolstad A.I., Svenungsson E., Lundberg I., Sturfelt G., Jonssen A., Truedsson L., Lima G., Alcocer-Varela J., Jonsson R., Gyllensten U.B., Harley J.B., Alarcon-Segovia D., Steinsson K., Alarcon-Riquelme M.E. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 2002, 32:666-669.
138. Tokuhiro S., Yamada R., Chang X., Suzuki A., Kochi Y., Sawada T., Suzuki M., Nagasaki M., Ohtsuki M., Ono M., Furukawa H., Nagashima M., Yoshino S., Mabuchi A., Sekine A., Saito S., Takahashi A., Tsunoda T., Nakamura Y., Yamamoto K. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 2003, 35:341-348.
139. Dicken J., Mildner A., Leshlowitz D., Touw I.V., Hantisteanu S., Jung S., Groner Y. Transcriptional reprogramming of CD11b+Esamhi dendritic cell identity and function by loss of Runx3. PLoS One 2013, 8:e77490.
140. Lotem J., Levanon D., Negreanu V., Leshkowitz D., Friedlander G., Groner Y. Runx3-mediated transcriptional program in cytotoxic lymphocytes. PLoS One 2013, 8:e80467.
141. Trynka G., Wijmenga C., van Heel D.A. A genetic perspective on coeliac disease. Trends Mol. Med. 2010, 16:537-550.
142. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., Lees C.W., Balschun T., Lee J., Roberts R., Anderson C.A., Bis J.C., Bumpstead S., Ellinghaus D., Festen E.M., Georges M., Green T., Haritunians T., Jostins L., Latiano A., Mathew C.G., Montgomery G.W., Prescott N.J., Raychaudhuri S., Rotter J.I., Schumm P., Sharma Y., Simms L.A., Taylor K.D., Whiteman D., Wijmenga C., Baldassano R.N., Barclay M., Bayless T.M., Brand S., Buning C., Cohen A., Colombel J.F., Cottone M., Stronati L., Denson T., De Vos M., D'Inca R., Dubinsky M., Edwards C., Florin T., Franchimont D., Gearry R., Glas J., Van Gossum A., Guthery S.L., Halfvarson J., Verspaget H.W., Hugot J.P., Karban A., Laukens D., Lawrance I., Lemann M., Levine A., Libioulle C., Louis E., Mowat C., Newman W., Panes J., Phillips A., Proctor D.D., Regueiro M., Russell R., Rutgeerts P., Sanderson J., Sans M., Seibold F., Steinhart A.H., Stokkers P.C., Torkvist L., Kullak-Ublick G., Wilson D., Walters T., Targan S.R., Brant S.R., Rioux J.D., D'Amato M., Weersma R.K., Kugathasan S., Griffiths A.M., Mansfield J.C., Vermeire S., Duerr R.H., Silverberg M.S., Satsangi J., Schreiber S., Cho J.H., Annese V., Hakonarson H., Daly M.J., Parkes M. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010, 42:1118-1125.
143. Anderson C.A., Boucher G., Lees C.W., Franke A., D'Amato M., Taylor K.D., Lee J.C., Goyette P., Imielinski M., Latiano A., Lagace C., Scott R., Amininejad L., Bumpstead S., Baidoo L., Baldassano R.N., Barclay M., Bayless T.M., Brand S., Buning C., Colombel J.F., Denson L.A., De Vos M., Dubinsky M., Edwards C., Ellinghaus D., Fehrmann R.S., Floyd J.A., Florin T., Franchimont D., Franke L., Georges M., Glas J., Glazer N.L., Guthery S.L., Haritunians T., Hayward N.K., Hugot J.P., Jobin G., Laukens D., Lawrance I., Lemann M., Levine A., Libioulle C., Louis E., McGovern D.P., Milla M., Montgomery G.W., Morley K.I., Mowat C., Ng A., Newman W., Ophoff R.A., Papi L., Palmieri O., Peyrin-Biroulet L., Panes J., Phillips A., Prescott N.J., Proctor D.D., Roberts R., Russell R., Rutgeerts P., Sanderson J., Sans M., Schumm P., Seibold F., Sharma Y., Simms L.A., Seielstad M., Steinhart A.H., Targan S.R., van den Berg L.H., Vatn M., Verspaget H., Walters T., Wijmenga C., Wilson D.C., Westra H.J., Xavier R.J., Zhao Z.Z., Ponsioen C.Y., Andersen V., Torkvist L., Gazouli M., Anagnou N.P., Karlsen T.H., Kupcinskas L., Sventoraityte J., Mansfield J.C., Kugathasan S., Silverberg M.S., Halfvarson J., Rotter J.I., Mathew C.G., Griffiths A.M., Gearry R., Ahmad T., Brant S.R., Chamaillard M., Satsangi J., Cho J.H., Schreiber S., Daly M.J., Barrett J.C., Parkes M., Annese V., Hakonarson H., Radford-Smith G., Duerr R.H., Vermeire S., Weersma R.K., Rioux J.D. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 2011, 43:246-252.
144. Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., Lee J.C., Schumm L.P., Sharma Y., Anderson C.A., Essers J., Mitrovic M., Ning K., Cleynen I., Theatre E., Spain S.L., Raychaudhuri S., Goyette P., Wei Z., Abraham C., Achkar J.P., Ahmad T., Amininejad L., Ananthakrishnan A.N., Andersen V., Andrews J.M., Baidoo L., Balschun T., Bampton P.A., Bitton A., Boucher G., Brand S., Buning C., Cohain A., Cichon S., D'Amato M., De Jong D., Devaney K.L., Dubinsky M., Edwards C., Ellinghaus D., Ferguson L.R., Franchimont D., Fransen K., Gearry R., Georges M., Gieger C., Glas J., Haritunians T., Hart A., Hawkey C., Hedl M., Hu X., Karlsen T.H., Kupcinskas L., Kugathasan S., Latiano A., Laukens D., Lawrance I.C., Lees C.W., Louis E., Mahy G., Mansfield J., Morgan A.R., Mowat C., Newman W., Palmieri O., Ponsioen C.Y., Potocnik U., Prescott N.J., Regueiro M., Rotter J.I., Russell R.K., Sanderson J.D., Sans M., Satsangi J., Schreiber S., Simms L.A., Sventoraityte J., Targan S.R., Taylor K.D., Tremelling M., Verspaget H.W., De Vos M., Wijmenga C., Wilson D.C., Winkelmann J., Xavier R.J., Zeissig S., Zhang B., Zhang C.K., Zhao H., Silverberg M.S., Annese V., Hakonarson H., Brant S.R., Radford-Smith G., Mathew C.G., Rioux J.D., Schadt E.E., Daly M.J., Franke A., Parkes M., Vermeire S., Barrett J.C., Cho J.H. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
145. Achyut B.R., Bader D.A., Robles A.I., Wangsa D., Harris C.C., Ried T., Yang L. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-beta signaling. PLoS Genet. 2013, 9:e1003251.
146. Valencia T., Kim J.Y., Abu-Baker S., Moscat-Pardos J., Ahn C.S., Reina-Campos M., Duran A., Castilla E.A., Metallo C.M., Diaz-Meco M.T., Moscat J. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell 2014, 26:121-135.
147. Duran A., Amanchy R., Linares J.F., Joshi J., Abu-Baker S., Porollo A., Hansen M., Moscat J., Diaz-Meco M.T. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol. Cell 2011, 44:134-146.
148. Banerji S., Cibulskis K., Rangel-Escareno C., Brown K.K., Carter S.L., Frederick A.M., Lawrence M.S., Sivachenko A.Y., Sougnez C., Zou L., Cortes M.L., Fernandez-Lopez J.C., Peng S., Ardlie K.G., Auclair D., Bautista-Pina V., Duke F., Francis J., Jung J., Maffuz-Aziz A., Onofrio R.C., Parkin M., Pho N.H., Quintanar-Jurado V., Ramos A.H., Rebollar-Vega R., Rodriguez-Cuevas S., Romero-Cordoba S.L., Schumacher S.E., Stransky N., Thompson K.M., Uribe-Figueroa L., Baselga J., Beroukhim R., Polyak K., Sgroi D.C., Richardson A.L., Jimenez-Sanchez G., Lander E.S., Gabriel S.B., Garraway L.A., Golub T.R., Melendez-Zajgla J., Toker A., Getz G., Hidalgo-Miranda A., Meyerson M. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012, 486:405-409.
149. Taniuchi I., Osato M., Ito Y. Runx1: no longer just for leukemia. EMBO J. 2012, 31:4098-4099.
150. Fijneman R.J., Anderson R.A., Richards E., Liu J., Tijssen M., Meijer G.A., Anderson J., Rod A., O'Sullivan M.G., Scott P.M., Cormier R.T. Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract. Cancer Sci. 2012, 103:593-599.